Download PDF
Tierarztl Prax Ausg K Kleintiere Heimtiere 2011; 39(03): 198-202
DOI: 10.1055/s-0038-1623578
Kasuistik
Schattauer GmbH

Fibroepithelial hyperplasia in an entire male cat: cytologic and histopathological features

Fibroepitheliale Hyperplasie bei einem unkastrierten Kater: zytologische und histopathologische Aspekte
E. Leidinger
1   In-Vitro-Labor für Veterinärmedizinische Diagnostik GmbH, Vienna, Austria
,
E. Hooijberg
1   In-Vitro-Labor für Veterinärmedizinische Diagnostik GmbH, Vienna, Austria
,
K. Sick
2   Dr. Kurt Sick, Veterinärhistologische Diagnostik, Feldkirchen/Carinthia, Austria
,
B. Reinelt
3   Tierärztliche Praxis, Leithaprodersdorf, Austria
,
G. Kirtz
1   In-Vitro-Labor für Veterinärmedizinische Diagnostik GmbH, Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received: 02 June 2010

Accepted after revision: 04 October 2010

Publication Date:
05 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Allen HI. Feline mammary hypertrophy. Vet Pathol 1973; 10: 501-508.
    CrossrefPubMedGoogle Scholar
  • 2 Bethlehem M, van der Luer RJ. Feliene fibroepitheliale hyperplasie biy drie gecastreerde katers na behandling mit progestativa. [Feline fibroepithelial hyperplasia in 3 castrated tomcats following treatment with progestagens]. Tijdschr Diergeneesk 1993; 15: 650-652.
    PubMedGoogle Scholar
  • 3 Chisholm H. Massive mammary enlargement in a cat. Can Vet J 1993; 34: 315.
    PubMedGoogle Scholar
  • 4 Concannon PW, Verstegen J. Some Unique Aspects of Canine and Feline Female Reproduction Important in Veterinary Practice. In: WASAVA Abstracts. Mexico City: 2005. Retrieved 6th June, 2010 from: http://www.vin.com/proceedings/Proceedings.plx?CID=WSAVA2005&PID=10995&Print=1&O=Generic
    Google Scholar
  • 5 Cowell RL, Tyler RD, Meinkoth JH, DeNicola DB. Diagnostic cytology and hematology of the dog and the cat. St. Louis: Mosby; 2008: 114.
    Google Scholar
  • 6 Dreier H-K. Reproduktionsmedizin: Gynäkologie, Andrologie, Gravidität, Partus und Puerperium. In: Katzenkrankheiten, Klinik und Therapie. 2. Band. Kraft W, Dürr UM, Hartmann K. Hrsg. Alfeld-Hannover: Schaper; 2003: 1109-1139
    Google Scholar
  • 7 Görlinger S, Kooistra HS, van den Broek A, Okkens AC. Treatment of fibroadenomatous hyperplasia in cats with aglépristone. J Vet Intern Med 2002; 16: 710-713.
    CrossrefPubMedGoogle Scholar
  • 8 Hayden DW, Johnston SD, Kiang DT, Johnson KH, Barnes DM. Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. Am J Vet Res 1981; 42: 1699-1703.
    PubMedGoogle Scholar
  • 9 Hayden DW, Barnes DM, Johnson KH. Morphologic changes in the mammary gland of megestrol acetate-treated and untreated cats: a retrospective study. Vet Pathol 1989; 26 (02) 104-113.
    CrossrefPubMedGoogle Scholar
  • 10 Hinton M, Gaskell CJ. Non-neoplastic mammary hypertrophy in the cat associated either with pregnancy or with oral progestagen therapy. Vet Rec 1977; 100: 277-280.
    CrossrefPubMedGoogle Scholar
  • 11 Jelinek F, Barton R, Posekana J, Hasonova L. Gynaecomastia in a tom-cat caused by cyproterone acetate: a case report. Veterinarni Medicina 2007; 52: 521-525.
    PubMedGoogle Scholar
  • 12 Koss LG, Melamed MR. Koss’ Diagnostic Cytology. Volume II. Philadelphia: Lippincott Williams & Wilkins; 2006: 1096-1097.
    Google Scholar
  • 13 MacDougall LD. Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. Can Vet J 2003; 44: 227-229.
    PubMedGoogle Scholar
  • 14 Martín JDe Las Mulas, Millán Y, Bautista MJ, Pérez J, Carrasco L. Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Res Vet Sci 2000; 68: 15-21.
    CrossrefPubMedGoogle Scholar
  • 15 Mandelli G, Finazzi M. Histopathologische Befunde bei dem Milchdrüsen-Hypertrophie-Fibroadenomkomplex der Katze [Histopathological findings in mammary hypertrophy-fibroadenoma complex of the cat]. Deutsch Tierärztl Wschr 1983; 90: 482-485.
    PubMedGoogle Scholar
  • 16 Meisl D, Hubler M, Arnold S. Der Progesteronantagonist Aglépristone (Alizine®) zur Behandlung der fibroepithelialen Hyperplasie der Mamma bei der Katze [Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in the cat with the progesterone antagonist Aglépristone (Alizine®)]. Schweiz Arch Tierheilk 2003; 145 (03) 130-136.
    CrossrefPubMedGoogle Scholar
  • 17 Mesher C. What is your diagnosis? 14-month old domestic cat. Vet Clin Pathol 1997; 26: 4 13.
    CrossrefPubMedGoogle Scholar
  • 18 Misdrop W, Else RW, Hellmen E, Lipscomb TP. Histological classification of mammary tumors of the dog and the cat. 2nd series. 1999. 7 11-29. Armed Forces Institute of Pathology, Washington DC.:
    Google Scholar
  • 19 Ordás J, Millán Y, de los Monteros AE, Reymundo C, de las Mulas JM. Immunohistochemical expression of progesterone receptors, growth hormone and insulin growth factor-I in feline fibroadenomatous change. Res Vet Sci 2004; 76: 227-233.
    CrossrefPubMedGoogle Scholar
  • 20 Pukay BP, Stevenson DA. Mammary hyperthrophy in an ovariohysterectomized cat. Can Vet J 1983; 24: 143-144.
    PubMedGoogle Scholar
  • 21 Wehrend A, Hospes R, Gruber AD. Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist. Vet Rec 2001; 148: 346-347.
    CrossrefPubMedGoogle Scholar
  • 22 Woodard JC. Fibroepithelial hyperplasia (feline mammary hyperthrophy). In: Veterinary Pathology. Jones TC, Hunt RD, King NW. eds. Baltimore: Williams & Wilkins; 1997: 1197-1200.
    Google Scholar